nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Hyperhidrosis—Irinotecan—lung cancer	0.00112	0.0014	CcSEcCtD
Flumazenil—Dizziness—Vinblastine—lung cancer	0.00112	0.0014	CcSEcCtD
Flumazenil—Urticaria—Vinorelbine—lung cancer	0.00111	0.0014	CcSEcCtD
Flumazenil—Mood swings—Methotrexate—lung cancer	0.00111	0.0014	CcSEcCtD
Flumazenil—Ataxia—Methotrexate—lung cancer	0.0011	0.00138	CcSEcCtD
Flumazenil—Ill-defined disorder—Etoposide—lung cancer	0.00109	0.00137	CcSEcCtD
Flumazenil—Anxiety—Cisplatin—lung cancer	0.00109	0.00137	CcSEcCtD
Flumazenil—Vision blurred—Paclitaxel—lung cancer	0.00109	0.00137	CcSEcCtD
Flumazenil—Hyperhidrosis—Gemcitabine—lung cancer	0.00109	0.00137	CcSEcCtD
Flumazenil—Hot flush—Doxorubicin—lung cancer	0.00109	0.00136	CcSEcCtD
Flumazenil—Visual impairment—Docetaxel—lung cancer	0.00109	0.00136	CcSEcCtD
Flumazenil—Dizziness—Topotecan—lung cancer	0.00108	0.00136	CcSEcCtD
Flumazenil—Tremor—Paclitaxel—lung cancer	0.00108	0.00136	CcSEcCtD
Flumazenil—Discomfort—Cisplatin—lung cancer	0.00108	0.00136	CcSEcCtD
Flumazenil—Hypotension—Irinotecan—lung cancer	0.00108	0.00136	CcSEcCtD
Flumazenil—Menopausal symptoms—Doxorubicin—lung cancer	0.00108	0.00135	CcSEcCtD
Flumazenil—Vomiting—Vinblastine—lung cancer	0.00107	0.00135	CcSEcCtD
Flumazenil—Dizziness—Erlotinib—lung cancer	0.00107	0.00135	CcSEcCtD
Flumazenil—Ill-defined disorder—Paclitaxel—lung cancer	0.00107	0.00135	CcSEcCtD
Flumazenil—Malaise—Etoposide—lung cancer	0.00106	0.00134	CcSEcCtD
Flumazenil—Agitation—Paclitaxel—lung cancer	0.00106	0.00133	CcSEcCtD
Flumazenil—Vertigo—Etoposide—lung cancer	0.00106	0.00133	CcSEcCtD
Flumazenil—Headache—Vinblastine—lung cancer	0.00106	0.00133	CcSEcCtD
Flumazenil—Hypotension—Gemcitabine—lung cancer	0.00105	0.00132	CcSEcCtD
Flumazenil—Insomnia—Irinotecan—lung cancer	0.00105	0.00131	CcSEcCtD
Flumazenil—Flushing—Docetaxel—lung cancer	0.00105	0.00131	CcSEcCtD
Flumazenil—Vomiting—Topotecan—lung cancer	0.00104	0.00131	CcSEcCtD
Flumazenil—Malaise—Paclitaxel—lung cancer	0.00104	0.00131	CcSEcCtD
Flumazenil—Paraesthesia—Irinotecan—lung cancer	0.00104	0.0013	CcSEcCtD
Flumazenil—Vertigo—Paclitaxel—lung cancer	0.00104	0.0013	CcSEcCtD
Flumazenil—Rash—Topotecan—lung cancer	0.00103	0.0013	CcSEcCtD
Flumazenil—Hypersensitivity—Vinorelbine—lung cancer	0.00103	0.0013	CcSEcCtD
Flumazenil—Dermatitis—Topotecan—lung cancer	0.00103	0.0013	CcSEcCtD
Flumazenil—Vomiting—Erlotinib—lung cancer	0.00103	0.0013	CcSEcCtD
Flumazenil—Dyspnoea—Irinotecan—lung cancer	0.00103	0.0013	CcSEcCtD
Flumazenil—Cough—Etoposide—lung cancer	0.00103	0.00129	CcSEcCtD
Flumazenil—Somnolence—Irinotecan—lung cancer	0.00103	0.00129	CcSEcCtD
Flumazenil—Headache—Topotecan—lung cancer	0.00103	0.00129	CcSEcCtD
Flumazenil—Tachycardia—Cisplatin—lung cancer	0.00103	0.00129	CcSEcCtD
Flumazenil—Rash—Erlotinib—lung cancer	0.00102	0.00128	CcSEcCtD
Flumazenil—Dermatitis—Erlotinib—lung cancer	0.00102	0.00128	CcSEcCtD
Flumazenil—Palpitations—Paclitaxel—lung cancer	0.00102	0.00128	CcSEcCtD
Flumazenil—Insomnia—Gemcitabine—lung cancer	0.00102	0.00128	CcSEcCtD
Flumazenil—Hypertension—Etoposide—lung cancer	0.00102	0.00128	CcSEcCtD
Flumazenil—Headache—Erlotinib—lung cancer	0.00102	0.00128	CcSEcCtD
Flumazenil—Diplopia—Doxorubicin—lung cancer	0.00102	0.00128	CcSEcCtD
Flumazenil—Hyperhidrosis—Cisplatin—lung cancer	0.00102	0.00128	CcSEcCtD
Flumazenil—Paraesthesia—Gemcitabine—lung cancer	0.00101	0.00127	CcSEcCtD
Flumazenil—Chills—Docetaxel—lung cancer	0.00101	0.00127	CcSEcCtD
Flumazenil—Cough—Paclitaxel—lung cancer	0.00101	0.00127	CcSEcCtD
Flumazenil—Asthenia—Vinorelbine—lung cancer	0.00101	0.00126	CcSEcCtD
Flumazenil—Arrhythmia—Docetaxel—lung cancer	0.00101	0.00126	CcSEcCtD
Flumazenil—Dyspnoea—Gemcitabine—lung cancer	0.00101	0.00126	CcSEcCtD
Flumazenil—Chest pain—Etoposide—lung cancer	0.001	0.00126	CcSEcCtD
Flumazenil—Nausea—Vinblastine—lung cancer	0.001	0.00126	CcSEcCtD
Flumazenil—Somnolence—Gemcitabine—lung cancer	0.001	0.00126	CcSEcCtD
Flumazenil—Affect lability—Doxorubicin—lung cancer	0.001	0.00126	CcSEcCtD
Flumazenil—Hypertension—Paclitaxel—lung cancer	0.000999	0.00125	CcSEcCtD
Flumazenil—Fatigue—Irinotecan—lung cancer	0.000998	0.00125	CcSEcCtD
Flumazenil—Pruritus—Vinorelbine—lung cancer	0.000993	0.00125	CcSEcCtD
Flumazenil—Discomfort—Etoposide—lung cancer	0.000992	0.00125	CcSEcCtD
Flumazenil—Pain—Irinotecan—lung cancer	0.00099	0.00124	CcSEcCtD
Flumazenil—Chest pain—Paclitaxel—lung cancer	0.000985	0.00124	CcSEcCtD
Flumazenil—Hypotension—Cisplatin—lung cancer	0.000982	0.00123	CcSEcCtD
Flumazenil—Anxiety—Paclitaxel—lung cancer	0.000981	0.00123	CcSEcCtD
Flumazenil—Erythema—Docetaxel—lung cancer	0.00098	0.00123	CcSEcCtD
Flumazenil—Nausea—Topotecan—lung cancer	0.000974	0.00122	CcSEcCtD
Flumazenil—Discomfort—Paclitaxel—lung cancer	0.000973	0.00122	CcSEcCtD
Flumazenil—Fatigue—Gemcitabine—lung cancer	0.000972	0.00122	CcSEcCtD
Flumazenil—Confusional state—Etoposide—lung cancer	0.000971	0.00122	CcSEcCtD
Flumazenil—Pain—Gemcitabine—lung cancer	0.000964	0.00121	CcSEcCtD
Flumazenil—Nausea—Erlotinib—lung cancer	0.000964	0.00121	CcSEcCtD
Flumazenil—Dry mouth—Paclitaxel—lung cancer	0.000963	0.00121	CcSEcCtD
Flumazenil—Mood swings—Doxorubicin—lung cancer	0.000962	0.00121	CcSEcCtD
Flumazenil—Ataxia—Doxorubicin—lung cancer	0.000955	0.0012	CcSEcCtD
Flumazenil—Feeling abnormal—Irinotecan—lung cancer	0.000954	0.0012	CcSEcCtD
Flumazenil—Confusional state—Paclitaxel—lung cancer	0.000952	0.00119	CcSEcCtD
Flumazenil—Paraesthesia—Cisplatin—lung cancer	0.000944	0.00118	CcSEcCtD
Flumazenil—Tachycardia—Etoposide—lung cancer	0.00094	0.00118	CcSEcCtD
Flumazenil—Dyspnoea—Cisplatin—lung cancer	0.000937	0.00118	CcSEcCtD
Flumazenil—Hyperhidrosis—Etoposide—lung cancer	0.000931	0.00117	CcSEcCtD
Flumazenil—Feeling abnormal—Gemcitabine—lung cancer	0.000929	0.00117	CcSEcCtD
Flumazenil—Dizziness—Vinorelbine—lung cancer	0.000928	0.00116	CcSEcCtD
Flumazenil—Tachycardia—Paclitaxel—lung cancer	0.000921	0.00116	CcSEcCtD
Flumazenil—Hyperhidrosis—Paclitaxel—lung cancer	0.000913	0.00115	CcSEcCtD
Flumazenil—Drowsiness—Methotrexate—lung cancer	0.000904	0.00114	CcSEcCtD
Flumazenil—Hypotension—Etoposide—lung cancer	0.0009	0.00113	CcSEcCtD
Flumazenil—Pain—Cisplatin—lung cancer	0.000899	0.00113	CcSEcCtD
Flumazenil—Vomiting—Vinorelbine—lung cancer	0.000892	0.00112	CcSEcCtD
Flumazenil—Rash—Vinorelbine—lung cancer	0.000885	0.00111	CcSEcCtD
Flumazenil—Dermatitis—Vinorelbine—lung cancer	0.000884	0.00111	CcSEcCtD
Flumazenil—Hypotension—Paclitaxel—lung cancer	0.000882	0.00111	CcSEcCtD
Flumazenil—Headache—Vinorelbine—lung cancer	0.000879	0.0011	CcSEcCtD
Flumazenil—Sweating—Methotrexate—lung cancer	0.000867	0.00109	CcSEcCtD
Flumazenil—Palpitations—Docetaxel—lung cancer	0.000866	0.00109	CcSEcCtD
Flumazenil—Feeling abnormal—Cisplatin—lung cancer	0.000866	0.00109	CcSEcCtD
Flumazenil—Paraesthesia—Etoposide—lung cancer	0.000864	0.00109	CcSEcCtD
Flumazenil—Dyspnoea—Etoposide—lung cancer	0.000858	0.00108	CcSEcCtD
Flumazenil—Somnolence—Etoposide—lung cancer	0.000856	0.00107	CcSEcCtD
Flumazenil—Cough—Docetaxel—lung cancer	0.000855	0.00107	CcSEcCtD
Flumazenil—Insomnia—Paclitaxel—lung cancer	0.000854	0.00107	CcSEcCtD
Flumazenil—Hypersensitivity—Irinotecan—lung cancer	0.000853	0.00107	CcSEcCtD
Flumazenil—Paraesthesia—Paclitaxel—lung cancer	0.000848	0.00106	CcSEcCtD
Flumazenil—Hypertension—Docetaxel—lung cancer	0.000846	0.00106	CcSEcCtD
Flumazenil—Dyspnoea—Paclitaxel—lung cancer	0.000842	0.00106	CcSEcCtD
Flumazenil—Somnolence—Paclitaxel—lung cancer	0.000839	0.00105	CcSEcCtD
Flumazenil—Chest pain—Docetaxel—lung cancer	0.000835	0.00105	CcSEcCtD
Flumazenil—Nausea—Vinorelbine—lung cancer	0.000834	0.00105	CcSEcCtD
Flumazenil—Asthenia—Irinotecan—lung cancer	0.00083	0.00104	CcSEcCtD
Flumazenil—Fatigue—Etoposide—lung cancer	0.00083	0.00104	CcSEcCtD
Flumazenil—Pain—Etoposide—lung cancer	0.000823	0.00103	CcSEcCtD
Flumazenil—Dry mouth—Docetaxel—lung cancer	0.000816	0.00102	CcSEcCtD
Flumazenil—Fatigue—Paclitaxel—lung cancer	0.000814	0.00102	CcSEcCtD
Flumazenil—Asthenia—Gemcitabine—lung cancer	0.000809	0.00102	CcSEcCtD
Flumazenil—Pain—Paclitaxel—lung cancer	0.000807	0.00101	CcSEcCtD
Flumazenil—Confusional state—Docetaxel—lung cancer	0.000807	0.00101	CcSEcCtD
Flumazenil—Pruritus—Gemcitabine—lung cancer	0.000798	0.001	CcSEcCtD
Flumazenil—Feeling abnormal—Etoposide—lung cancer	0.000793	0.000996	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—lung cancer	0.000783	0.000983	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—lung cancer	0.000782	0.000982	CcSEcCtD
Flumazenil—Tachycardia—Docetaxel—lung cancer	0.000781	0.00098	CcSEcCtD
Flumazenil—Feeling abnormal—Paclitaxel—lung cancer	0.000778	0.000976	CcSEcCtD
Flumazenil—Hypersensitivity—Cisplatin—lung cancer	0.000774	0.000972	CcSEcCtD
Flumazenil—Dizziness—Irinotecan—lung cancer	0.000765	0.000961	CcSEcCtD
Flumazenil—Urticaria—Etoposide—lung cancer	0.000765	0.00096	CcSEcCtD
Flumazenil—Tinnitus—Methotrexate—lung cancer	0.000757	0.00095	CcSEcCtD
Flumazenil—Asthenia—Cisplatin—lung cancer	0.000754	0.000946	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—lung cancer	0.000751	0.000942	CcSEcCtD
Flumazenil—Urticaria—Paclitaxel—lung cancer	0.00075	0.000941	CcSEcCtD
Flumazenil—Hypotension—Docetaxel—lung cancer	0.000748	0.000938	CcSEcCtD
Flumazenil—Vomiting—Irinotecan—lung cancer	0.000736	0.000924	CcSEcCtD
Flumazenil—Rash—Irinotecan—lung cancer	0.00073	0.000916	CcSEcCtD
Flumazenil—Dermatitis—Irinotecan—lung cancer	0.000729	0.000915	CcSEcCtD
Flumazenil—Chills—Methotrexate—lung cancer	0.000728	0.000914	CcSEcCtD
Flumazenil—Headache—Irinotecan—lung cancer	0.000725	0.00091	CcSEcCtD
Flumazenil—Insomnia—Docetaxel—lung cancer	0.000724	0.000908	CcSEcCtD
Flumazenil—Paraesthesia—Docetaxel—lung cancer	0.000718	0.000902	CcSEcCtD
Flumazenil—Vomiting—Gemcitabine—lung cancer	0.000717	0.0009	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—lung cancer	0.000715	0.000898	CcSEcCtD
Flumazenil—Dyspnoea—Docetaxel—lung cancer	0.000713	0.000895	CcSEcCtD
Flumazenil—Somnolence—Docetaxel—lung cancer	0.000711	0.000893	CcSEcCtD
Flumazenil—Rash—Gemcitabine—lung cancer	0.000711	0.000892	CcSEcCtD
Flumazenil—Dermatitis—Gemcitabine—lung cancer	0.00071	0.000892	CcSEcCtD
Flumazenil—Hypersensitivity—Etoposide—lung cancer	0.000709	0.00089	CcSEcCtD
Flumazenil—Erythema—Methotrexate—lung cancer	0.000707	0.000887	CcSEcCtD
Flumazenil—Headache—Gemcitabine—lung cancer	0.000706	0.000887	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—lung cancer	0.000699	0.000878	CcSEcCtD
Flumazenil—Hypersensitivity—Paclitaxel—lung cancer	0.000695	0.000873	CcSEcCtD
Flumazenil—Asthenia—Etoposide—lung cancer	0.000691	0.000867	CcSEcCtD
Flumazenil—Fatigue—Docetaxel—lung cancer	0.00069	0.000866	CcSEcCtD
Flumazenil—Nausea—Irinotecan—lung cancer	0.000687	0.000863	CcSEcCtD
Flumazenil—Pain—Docetaxel—lung cancer	0.000684	0.000859	CcSEcCtD
Flumazenil—Pruritus—Etoposide—lung cancer	0.000681	0.000855	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—lung cancer	0.000677	0.00085	CcSEcCtD
Flumazenil—Asthenia—Paclitaxel—lung cancer	0.000677	0.00085	CcSEcCtD
Flumazenil—Nausea—Gemcitabine—lung cancer	0.00067	0.000841	CcSEcCtD
Flumazenil—Vomiting—Cisplatin—lung cancer	0.000668	0.000839	CcSEcCtD
Flumazenil—Pruritus—Paclitaxel—lung cancer	0.000668	0.000838	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—lung cancer	0.000666	0.000836	CcSEcCtD
Flumazenil—Rash—Cisplatin—lung cancer	0.000663	0.000832	CcSEcCtD
Flumazenil—Dermatitis—Cisplatin—lung cancer	0.000662	0.000831	CcSEcCtD
Flumazenil—Feeling abnormal—Docetaxel—lung cancer	0.000659	0.000828	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—lung cancer	0.000656	0.000823	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—lung cancer	0.000655	0.000823	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—lung cancer	0.000652	0.000819	CcSEcCtD
Flumazenil—Malaise—Methotrexate—lung cancer	0.000637	0.0008	CcSEcCtD
Flumazenil—Dizziness—Etoposide—lung cancer	0.000637	0.000799	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—lung cancer	0.000635	0.000797	CcSEcCtD
Flumazenil—Chills—Doxorubicin—lung cancer	0.000631	0.000792	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—lung cancer	0.000628	0.000788	CcSEcCtD
Flumazenil—Dizziness—Paclitaxel—lung cancer	0.000624	0.000784	CcSEcCtD
Flumazenil—Nausea—Cisplatin—lung cancer	0.000624	0.000784	CcSEcCtD
Flumazenil—Cough—Methotrexate—lung cancer	0.000617	0.000774	CcSEcCtD
Flumazenil—Vomiting—Etoposide—lung cancer	0.000612	0.000768	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—lung cancer	0.000612	0.000768	CcSEcCtD
Flumazenil—Rash—Etoposide—lung cancer	0.000607	0.000762	CcSEcCtD
Flumazenil—Dermatitis—Etoposide—lung cancer	0.000606	0.000761	CcSEcCtD
Flumazenil—Headache—Etoposide—lung cancer	0.000603	0.000757	CcSEcCtD
Flumazenil—Chest pain—Methotrexate—lung cancer	0.000602	0.000755	CcSEcCtD
Flumazenil—Tension—Doxorubicin—lung cancer	0.0006	0.000754	CcSEcCtD
Flumazenil—Vomiting—Paclitaxel—lung cancer	0.0006	0.000753	CcSEcCtD
Flumazenil—Rash—Paclitaxel—lung cancer	0.000595	0.000747	CcSEcCtD
Flumazenil—Dermatitis—Paclitaxel—lung cancer	0.000595	0.000746	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—lung cancer	0.000594	0.000746	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—lung cancer	0.000594	0.000746	CcSEcCtD
Flumazenil—Headache—Paclitaxel—lung cancer	0.000591	0.000742	CcSEcCtD
Flumazenil—Hypersensitivity—Docetaxel—lung cancer	0.000589	0.00074	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—lung cancer	0.000581	0.00073	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—lung cancer	0.000577	0.000724	CcSEcCtD
Flumazenil—Asthenia—Docetaxel—lung cancer	0.000574	0.000721	CcSEcCtD
Flumazenil—Nausea—Etoposide—lung cancer	0.000572	0.000718	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—lung cancer	0.000568	0.000713	CcSEcCtD
Flumazenil—Pruritus—Docetaxel—lung cancer	0.000566	0.000711	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—lung cancer	0.000562	0.000706	CcSEcCtD
Flumazenil—Nausea—Paclitaxel—lung cancer	0.000561	0.000704	CcSEcCtD
Flumazenil—Hyperhidrosis—Methotrexate—lung cancer	0.000557	0.0007	CcSEcCtD
Flumazenil—GABRA3—Neuronal System—CHRNA3—lung cancer	0.000554	0.00272	CbGpPWpGaD
Flumazenil—Malaise—Doxorubicin—lung cancer	0.000552	0.000693	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—lung cancer	0.00055	0.00069	CcSEcCtD
Flumazenil—GABRA6—Neuronal System—ADCY1—lung cancer	0.000547	0.00269	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—CHRNA3—lung cancer	0.000544	0.00268	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—CHRNA3—lung cancer	0.000541	0.00266	CbGpPWpGaD
Flumazenil—Palpitations—Doxorubicin—lung cancer	0.000541	0.000679	CcSEcCtD
Flumazenil—GABRA4—Neuronal System—ADCY1—lung cancer	0.00054	0.00265	CbGpPWpGaD
Flumazenil—Hypotension—Methotrexate—lung cancer	0.000539	0.000676	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—FOXO3—lung cancer	0.000537	0.00264	CbGpPWpGaD
Flumazenil—Cough—Doxorubicin—lung cancer	0.000534	0.00067	CcSEcCtD
Flumazenil—GABRA5—Neuronal System—GNG11—lung cancer	0.000534	0.00262	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—CHRNA3—lung cancer	0.000531	0.00261	CbGpPWpGaD
Flumazenil—Dizziness—Docetaxel—lung cancer	0.000529	0.000664	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—lung cancer	0.000528	0.000663	CcSEcCtD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000528	0.0026	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—GNG11—lung cancer	0.000524	0.00258	CbGpPWpGaD
Flumazenil—Insomnia—Methotrexate—lung cancer	0.000522	0.000655	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—lung cancer	0.000521	0.000654	CcSEcCtD
Flumazenil—Anxiety—Doxorubicin—lung cancer	0.000519	0.000652	CcSEcCtD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000519	0.00255	CbGpPWpGaD
Flumazenil—Paraesthesia—Methotrexate—lung cancer	0.000518	0.00065	CcSEcCtD
Flumazenil—GABRA1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000515	0.00253	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—GNG11—lung cancer	0.000515	0.00253	CbGpPWpGaD
Flumazenil—Discomfort—Doxorubicin—lung cancer	0.000515	0.000646	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—lung cancer	0.000514	0.000645	CcSEcCtD
Flumazenil—Somnolence—Methotrexate—lung cancer	0.000513	0.000644	CcSEcCtD
Flumazenil—GABRB3—Neuronal System—GNG11—lung cancer	0.000512	0.00251	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00051	0.00251	CbGpPWpGaD
Flumazenil—Dry mouth—Doxorubicin—lung cancer	0.000509	0.000639	CcSEcCtD
Flumazenil—Vomiting—Docetaxel—lung cancer	0.000509	0.000639	CcSEcCtD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000506	0.00249	CbGpPWpGaD
Flumazenil—Rash—Docetaxel—lung cancer	0.000504	0.000633	CcSEcCtD
Flumazenil—Dermatitis—Docetaxel—lung cancer	0.000504	0.000633	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—lung cancer	0.000503	0.000632	CcSEcCtD
Flumazenil—GABRG2—Neuronal System—GNG11—lung cancer	0.000502	0.00247	CbGpPWpGaD
Flumazenil—GABRA6—Orphan transporters—CREBBP—lung cancer	0.000502	0.00247	CbGpPWpGaD
Flumazenil—Headache—Docetaxel—lung cancer	0.000501	0.000629	CcSEcCtD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000497	0.00244	CbGpPWpGaD
Flumazenil—Fatigue—Methotrexate—lung cancer	0.000497	0.000624	CcSEcCtD
Flumazenil—GABRA4—Orphan transporters—CREBBP—lung cancer	0.000496	0.00244	CbGpPWpGaD
Flumazenil—Pain—Methotrexate—lung cancer	0.000493	0.000619	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—lung cancer	0.000487	0.000612	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—lung cancer	0.000483	0.000606	CcSEcCtD
Flumazenil—GABRA5—Neuronal System—ADCY1—lung cancer	0.00048	0.00236	CbGpPWpGaD
Flumazenil—Nausea—Docetaxel—lung cancer	0.000475	0.000597	CcSEcCtD
Flumazenil—Feeling abnormal—Methotrexate—lung cancer	0.000475	0.000597	CcSEcCtD
Flumazenil—GABRA3—Neuronal System—ADCY1—lung cancer	0.000471	0.00232	CbGpPWpGaD
Flumazenil—Hypotension—Doxorubicin—lung cancer	0.000467	0.000586	CcSEcCtD
Flumazenil—GABRA1—Neuronal System—CHRNA3—lung cancer	0.000464	0.00228	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—ADCY1—lung cancer	0.000463	0.00228	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—ADCY1—lung cancer	0.00046	0.00226	CbGpPWpGaD
Flumazenil—Urticaria—Methotrexate—lung cancer	0.000458	0.000575	CcSEcCtD
Flumazenil—GABRG2—Neuronal System—ADCY1—lung cancer	0.000452	0.00222	CbGpPWpGaD
Flumazenil—Insomnia—Doxorubicin—lung cancer	0.000452	0.000567	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—lung cancer	0.000448	0.000563	CcSEcCtD
Flumazenil—Dyspnoea—Doxorubicin—lung cancer	0.000445	0.000559	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—lung cancer	0.000444	0.000557	CcSEcCtD
Flumazenil—GABRA5—Orphan transporters—CREBBP—lung cancer	0.000441	0.00217	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—GNG11—lung cancer	0.000439	0.00216	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000435	0.00214	CbGpPWpGaD
Flumazenil—GABRA3—Orphan transporters—CREBBP—lung cancer	0.000433	0.00213	CbGpPWpGaD
Flumazenil—Fatigue—Doxorubicin—lung cancer	0.00043	0.00054	CcSEcCtD
Flumazenil—Pain—Doxorubicin—lung cancer	0.000427	0.000536	CcSEcCtD
Flumazenil—GABRA2—Orphan transporters—CREBBP—lung cancer	0.000425	0.00209	CbGpPWpGaD
Flumazenil—Hypersensitivity—Methotrexate—lung cancer	0.000425	0.000533	CcSEcCtD
Flumazenil—GABRB3—Orphan transporters—CREBBP—lung cancer	0.000422	0.00208	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—CREBBP—lung cancer	0.000415	0.00204	CbGpPWpGaD
Flumazenil—Asthenia—Methotrexate—lung cancer	0.000414	0.000519	CcSEcCtD
Flumazenil—Feeling abnormal—Doxorubicin—lung cancer	0.000411	0.000517	CcSEcCtD
Flumazenil—Pruritus—Methotrexate—lung cancer	0.000408	0.000512	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000405	0.00199	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000401	0.00197	CbGpPWpGaD
Flumazenil—Urticaria—Doxorubicin—lung cancer	0.000397	0.000498	CcSEcCtD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000396	0.00195	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—ADCY1—lung cancer	0.000395	0.00194	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000383	0.00188	CbGpPWpGaD
Flumazenil—Dizziness—Methotrexate—lung cancer	0.000381	0.000479	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000381	0.00187	CbGpPWpGaD
Flumazenil—Hypersensitivity—Doxorubicin—lung cancer	0.000368	0.000462	CcSEcCtD
Flumazenil—Vomiting—Methotrexate—lung cancer	0.000367	0.00046	CcSEcCtD
Flumazenil—Rash—Methotrexate—lung cancer	0.000364	0.000456	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—lung cancer	0.000363	0.000456	CcSEcCtD
Flumazenil—GABRA1—Orphan transporters—CREBBP—lung cancer	0.000363	0.00178	CbGpPWpGaD
Flumazenil—Headache—Methotrexate—lung cancer	0.000361	0.000453	CcSEcCtD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000361	0.00177	CbGpPWpGaD
Flumazenil—Asthenia—Doxorubicin—lung cancer	0.000358	0.00045	CcSEcCtD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000356	0.00175	CbGpPWpGaD
Flumazenil—Pruritus—Doxorubicin—lung cancer	0.000353	0.000443	CcSEcCtD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000352	0.00173	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—APC—lung cancer	0.000351	0.00173	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000346	0.0017	CbGpPWpGaD
Flumazenil—Nausea—Methotrexate—lung cancer	0.000343	0.00043	CcSEcCtD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.00034	0.00167	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000338	0.00166	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000336	0.00165	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000335	0.00165	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000332	0.00163	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000332	0.00163	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000331	0.00163	CbGpPWpGaD
Flumazenil—Dizziness—Doxorubicin—lung cancer	0.00033	0.000414	CcSEcCtD
Flumazenil—GABRA6—Transmembrane transport of small molecules—GNG11—lung cancer	0.000327	0.00161	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—GNG11—lung cancer	0.000323	0.00159	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000321	0.00158	CbGpPWpGaD
Flumazenil—Vomiting—Doxorubicin—lung cancer	0.000317	0.000399	CcSEcCtD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000316	0.00156	CbGpPWpGaD
Flumazenil—Rash—Doxorubicin—lung cancer	0.000315	0.000395	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—lung cancer	0.000315	0.000395	CcSEcCtD
Flumazenil—Headache—Doxorubicin—lung cancer	0.000313	0.000393	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—MAP2K1—lung cancer	0.000311	0.00153	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000311	0.00153	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000305	0.0015	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000303	0.00149	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—BRAF—lung cancer	0.000302	0.00148	CbGpPWpGaD
Flumazenil—GABRA6—Ion channel transport—RAF1—lung cancer	0.000298	0.00147	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—BRAF—lung cancer	0.000298	0.00147	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000298	0.00146	CbGpPWpGaD
Flumazenil—Nausea—Doxorubicin—lung cancer	0.000297	0.000372	CcSEcCtD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000295	0.00145	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—RAF1—lung cancer	0.000294	0.00145	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000294	0.00145	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000294	0.00145	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000294	0.00145	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ADCY1—lung cancer	0.00029	0.00143	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCG2—lung cancer	0.00029	0.00143	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.00029	0.00142	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.00029	0.00142	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000289	0.00142	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—GNG11—lung cancer	0.000287	0.00141	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000285	0.0014	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000284	0.0014	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000283	0.00139	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000282	0.00139	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—GNG11—lung cancer	0.000282	0.00138	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000278	0.00137	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000277	0.00136	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000277	0.00136	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—RAF1—lung cancer	0.000276	0.00136	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—GNG11—lung cancer	0.000275	0.00135	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—TF—lung cancer	0.000273	0.00134	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—GNG11—lung cancer	0.00027	0.00133	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—TF—lung cancer	0.00027	0.00133	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MTOR—lung cancer	0.000269	0.00132	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—BRAF—lung cancer	0.000265	0.0013	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000263	0.00129	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000262	0.00129	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—RAF1—lung cancer	0.000262	0.00129	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.00026	0.00128	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—BRAF—lung cancer	0.00026	0.00128	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000258	0.00127	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000258	0.00127	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—RAF1—lung cancer	0.000257	0.00126	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000256	0.00126	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—BRAF—lung cancer	0.000254	0.00125	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000253	0.00125	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000253	0.00125	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—MDM2—lung cancer	0.000253	0.00124	CbGpPWpGaD
Flumazenil—GABRA2—Ion channel transport—RAF1—lung cancer	0.000253	0.00124	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—RAF1—lung cancer	0.000252	0.00124	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—RAF1—lung cancer	0.000251	0.00123	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—MDM2—lung cancer	0.00025	0.00123	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000249	0.00123	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000249	0.00122	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000249	0.00122	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—RAF1—lung cancer	0.000249	0.00122	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CASP3—lung cancer	0.000248	0.00122	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000247	0.00122	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000247	0.00122	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—RAF1—lung cancer	0.000246	0.00121	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000243	0.00119	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000243	0.00119	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000243	0.00119	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000242	0.00119	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—JUN—lung cancer	0.00024	0.00118	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—TF—lung cancer	0.00024	0.00118	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000236	0.00116	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—TF—lung cancer	0.000235	0.00116	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—TF—lung cancer	0.000231	0.00114	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—BRAF—lung cancer	0.000231	0.00114	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—TF—lung cancer	0.00023	0.00113	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—BRAF—lung cancer	0.000228	0.00112	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—TF—lung cancer	0.000226	0.00111	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—MDM2—lung cancer	0.000222	0.00109	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—RAF1—lung cancer	0.000221	0.00109	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—BRAF—lung cancer	0.000218	0.00107	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—MDM2—lung cancer	0.000218	0.00107	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—RAF1—lung cancer	0.000217	0.00107	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—SRC—lung cancer	0.000216	0.00106	CbGpPWpGaD
Flumazenil—GABRA1—Ion channel transport—RAF1—lung cancer	0.000215	0.00106	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000214	0.00105	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000213	0.00105	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—MDM2—lung cancer	0.000213	0.00105	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000212	0.00104	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000212	0.00104	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—RAF1—lung cancer	0.000212	0.00104	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000209	0.00103	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000208	0.00102	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000208	0.00102	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—STAT3—lung cancer	0.000208	0.00102	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—BRAF—lung cancer	0.000203	0.000997	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000199	0.00098	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—BRAF—lung cancer	0.000199	0.000979	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAPK3—lung cancer	0.000199	0.000977	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—TF—lung cancer	0.000197	0.00097	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—BRAF—lung cancer	0.000196	0.000963	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—BRAF—lung cancer	0.000194	0.000956	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—MDM2—lung cancer	0.000194	0.000953	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000194	0.000952	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—RAF1—lung cancer	0.000193	0.000949	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—MDM2—lung cancer	0.000191	0.000941	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—BRAF—lung cancer	0.000191	0.000939	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—RAF1—lung cancer	0.000191	0.000937	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—AVP—lung cancer	0.000189	0.000931	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—AVP—lung cancer	0.000187	0.00092	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000185	0.000907	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000183	0.000902	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—MDM2—lung cancer	0.000183	0.000898	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000182	0.000896	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—RAF1—lung cancer	0.000182	0.000894	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000181	0.000891	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000179	0.000878	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—MDM2—lung cancer	0.00017	0.000836	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—RAF1—lung cancer	0.000169	0.000833	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000169	0.000831	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—BRAF—lung cancer	0.000167	0.000821	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—MDM2—lung cancer	0.000167	0.000821	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—RAF1—lung cancer	0.000166	0.000818	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—AVP—lung cancer	0.000166	0.000817	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—MDM2—lung cancer	0.000164	0.000806	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—RAF1—lung cancer	0.000163	0.000804	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—AVP—lung cancer	0.000163	0.000802	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—MDM2—lung cancer	0.000163	0.000801	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—RAF1—lung cancer	0.000162	0.000798	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000162	0.000796	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000161	0.000791	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—AVP—lung cancer	0.00016	0.000789	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—MDM2—lung cancer	0.00016	0.000787	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—RAF1—lung cancer	0.000159	0.000784	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—AVP—lung cancer	0.000159	0.000783	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000159	0.000782	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000158	0.000777	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—AVP—lung cancer	0.000156	0.000769	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000156	0.000768	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000155	0.000764	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000155	0.000763	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000154	0.000759	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000152	0.00075	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—HRAS—lung cancer	0.000152	0.000746	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000152	0.000745	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—APOA1—lung cancer	0.000145	0.000712	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—APOA1—lung cancer	0.000143	0.000703	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—MDM2—lung cancer	0.00014	0.000688	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—RAF1—lung cancer	0.000139	0.000685	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—HRAS—lung cancer	0.000139	0.000682	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—HRAS—lung cancer	0.000137	0.000674	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	0.000137	0.000672	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—AKT1—lung cancer	0.000134	0.000659	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000133	0.000655	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000132	0.000651	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—APOA1—lung cancer	0.000127	0.000625	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—APOA1—lung cancer	0.000125	0.000614	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—APOA1—lung cancer	0.000123	0.000603	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000123	0.000603	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—APOA1—lung cancer	0.000122	0.000599	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—HRAS—lung cancer	0.000122	0.000598	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000121	0.000595	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—APOA1—lung cancer	0.00012	0.000588	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—HRAS—lung cancer	0.00012	0.000588	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000117	0.000578	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000117	0.000575	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—HRAS—lung cancer	0.000117	0.000574	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ALB—lung cancer	0.000115	0.000564	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000115	0.000563	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ALB—lung cancer	0.000113	0.000557	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000108	0.000529	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—HRAS—lung cancer	0.000106	0.000523	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000106	0.000519	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—HRAS—lung cancer	0.000105	0.000516	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000105	0.000514	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000104	0.00051	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—RAF1—lung cancer	0.000104	0.00051	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000103	0.000507	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—RAF1—lung cancer	0.000102	0.000504	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000101	0.000498	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ALB—lung cancer	0.000101	0.000495	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	0.0001	0.000493	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ALB—lung cancer	9.89e-05	0.000486	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ALB—lung cancer	9.72e-05	0.000478	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ALB—lung cancer	9.65e-05	0.000475	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	9.48e-05	0.000466	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—HRAS—lung cancer	9.33e-05	0.000459	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—HRAS—lung cancer	9.16e-05	0.00045	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—RAF1—lung cancer	9.11e-05	0.000448	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—HRAS—lung cancer	9e-05	0.000443	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—RAF1—lung cancer	8.94e-05	0.00044	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—HRAS—lung cancer	8.94e-05	0.00044	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.85e-05	0.000435	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—RAF1—lung cancer	8.79e-05	0.000432	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—HRAS—lung cancer	8.78e-05	0.000432	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—RAF1—lung cancer	8.73e-05	0.000429	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	8.57e-05	0.000422	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	8.29e-05	0.000407	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—HRAS—lung cancer	7.68e-05	0.000377	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	7.49e-05	0.000368	CbGpPWpGaD
